EUVIMEDEUVIMED entdecken
Crossref

Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene

Dipika Shaw iD, Sunil Dogra iD, Shreya Singh, Shikha Shah iD, Tarun Narang iD, Harsimran Kaur iD, Kamini Walia, Anup Ghosh iD, Sanjeev Handa iD, Arunaloke Chakrabarti iD, Shivaprakash Mandya Rudramurthy iD

Mycoses · 2024

DOI: 10.1111/myc.13778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2024. Verfasst von Dipika Shaw und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Antifungal Agents, Itraconazole, Mutation, Squalene Monooxygenase. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Over the past decades, the increasing incidence of recurrent dermatophytosis associated with terbinafine‐resistant Trichophyton has posed a serious challenge in management of dermatophytosis. Independent reports of failure of treatment and high minimum inhibitory concentrations (MIC) of antifungals are available, but data correlating MIC and clinical outcomes is still sparse. Therefore, the present study was conducted to evaluate the outcomes of systemic treatment of dermatophytosis and its correlation with MIC of the etiological agents isolated from such patients.

Methods

Retrospective analysis of 587 consecutive patients with dermatophytosis was done from March 2017 to March 2019. Demographic and clinical details of the patients were noted, along with the results of direct microscopy and fungal culture. The isolates were identified by sequencing the internal transcribed spacer region of rDNA. Antifungal susceptibility testing was performed following the CLSI M38 protocol. Mutation in the squalene epoxidase ( SE ) gene was detected by DNA sequencing and ARMS‐PCR. Based on the culture‐positivity and prescribed systemic antifungal, patients were categorised into Group I culture‐positive cases treated with systemic terbinafine and Group II culture‐positive cases treated with systemic itraconazole, each for a total period of 12 weeks.

Results

In the present study, 477 (81.39%) were culture‐positive; however, 12 weeks follow‐up was available for 294 patients (Group I‐157 and Group II‐137) who were included for statistical analysis. In both groups [Group I‐37/63 (51.4%) and Group II‐14/54 (58.3%)], a better cure rate was observed if the initiation of therapy was performed within

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsItraconazoleMutationSqualene MonooxygenaseTerbinafineTineaTrichophytonAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultDrug Resistance, FungalMicrobial Sensitivity TestsRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

antifungal resistancedermatophytosisepidemiologyitraconazoleterbinafinetinea corporis

Substanzen

Antifungal AgentsItraconazoleSqualene MonooxygenaseTerbinafine

Autor:innen und Institutionen

  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Microbiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
  • Department of Dermatology, Venerology & Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Indian Council of Medical Research, New Delhi, India.

ORCID-Profile: Dipika Shaw, Sunil Dogra, Shikha Shah, Tarun Narang, Harsimran Kaur, Anup Ghosh, Sanjeev Handa, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Shaw, D., Dogra, S., Singh, S., Shah, S., Narang, T., Kaur, H., Walia, K., Ghosh, A., Handa, S., Chakrabarti, A., & Rudramurthy, S. M. (2024). Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene. Mycoses. https://doi.org/10.1111/myc.13778

Vancouver

Shaw D, Dogra S, Singh S, Shah S, Narang T, Kaur H, et al. Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene. Mycoses. 2024. doi:10.1111/myc.13778

BibTeX
@article{Shaw2024,
  author = {Shaw, Dipika and Dogra, Sunil and Singh, Shreya and Shah, Shikha and Narang, Tarun and Kaur, Harsimran and Walia, Kamini and Ghosh, Anup and Handa, Sanjeev and Chakrabarti, Arunaloke and Rudramurthy, Shivaprakash Mandya},
  title = {Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene},
  journal = {Mycoses},
  year = {2024},
  doi = {10.1111/myc.13778}
}
Kostenlos starten →